MDD(Mild Cognitive Impairment Delirium Dementia) Cohort
NCT ID: NCT05113446
Last Updated: 2022-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
163 participants
OBSERVATIONAL
2021-07-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Dementia conversion rate and conversion period of subjects with mild cognitive impairment with delirium and it identifies the effect of delirium on dementia conversion.
* Develop an AI(Artificial intelligence) algorithm for predicting dementia transition in subjects with mild cognitive impairment based on the research results of the 1st, 2nd, and 3rd years.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Diagnosis and Treatment Standardization of Delirium
NCT03199859
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease
NCT02137460
Incidence of Delirium in Inpatient Elderly Patients
NCT04177589
A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting
NCT03448445
Delirium and Cognitive Impairment Development in Hospitalized Older Adults Under Isolation Conditions
NCT07114458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MCI(Mild Cognitive Impairment) group
* Inclusion criteria : Patients 65 years of age or older who are admitted to a LTC(long-term care) facilities, Patients diagnosed with mild cognitive impairment by doctors, Patients with a score of 18 or more and 23 or less on the Mini-Mental State Examination
* Exclusion criteria : Patients unable to measure the delirium assessment tool, The Short Confusion Assessment Methods (S-CAM) (Inouye, 2014) due to severe vision and hearing problems, Patients with serious psychiatric or neurological diagnosis,Patients who died or were transferred on the day of admission, Patients receiving emergency treatment at the time of the delirium assessment or unable to measure or intervene with S-CAM due to hospital circumstances
Delirium assessment using S-CAM
Twice a day, the rounds of nurses in shifts, 8:00 am - 10:00 am, 4:00 pm - 6:00 pm Trained research assistants assessed delirium using S-CAM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Delirium assessment using S-CAM
Twice a day, the rounds of nurses in shifts, 8:00 am - 10:00 am, 4:00 pm - 6:00 pm Trained research assistants assessed delirium using S-CAM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with mild cognitive impairment by doctors
* Patients with a score of 18 or more and 23 or less on the Mini-Mental State Examination
Exclusion Criteria
* Patients with serious psychiatric or neurological diagnosis,Patients who expire or were transferred on the day of admission -
* Patients receiving emergency treatment at the time of the delirium assessment or unable to measure or intervene with S-CAM due to hospital circumstances
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Keimyung University Dongsan Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kyoung ja Moon
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yangsan Seoul long-term care (LTC) facilities
Daegu, Gyeongsangnam-do, South Korea
Gunsan Chamsarang long-term care (LTC) facilities
Daegu, Jeollabuk-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Moon KJ, Park M. Protocol for a prospective, longitudinal cohort study on the incidence of dementia after the onset of delirium in patients with mild cognitive impairment: MDDCohort (Mild Cognitive Impairment Delirium Dementia). BMC Geriatr. 2024 Nov 7;24(1):922. doi: 10.1186/s12877-024-05480-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019R1I1A3A0106056112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.